Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infections”

Showing 20 of 0 results

Not applicableLooking for participantsNCT02647879
What this trial is testing

Treatment as Prevention for Hepatitis C in Iceland

Who this might be right for
Hepatitis C
Landspitali University Hospital 1,000
Early research (Phase 1)Study completedNCT02565862
What this trial is testing

A Drug-drug Interaction Study Between Daclatasvir and Metformin

Who this might be right for
Hepatitis CDiabetes MellitusInsulin Resistance
Radboud University Medical Center 20
Not applicableStudy completedNCT02116179
What this trial is testing

DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients

Who this might be right for
Human Immunodeficiency VirusAcquired Immunodeficiency SyndromeHepatitis C
University of Delaware 201
Large-scale testing (Phase 3)Study completedNCT00265642
What this trial is testing

Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
ANRS, Emerging Infectious Diseases 166
Early research (Phase 1)Study completedNCT00983957
What this trial is testing

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 47
Early research (Phase 1)Study completedNCT00857311
What this trial is testing

MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 17
Testing effectiveness (Phase 2)Study completedNCT01441180
What this trial is testing

GS-7977 With Ribavirin for Hepatitis C (SPARE)

Who this might be right for
Hepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Ended earlyNCT02791256
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 23
Testing effectiveness (Phase 2)Study completedNCT02254707
What this trial is testing

Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 96
Not applicableUnknownNCT01426204
What this trial is testing

Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)

Who this might be right for
Hepatitis C
Closter Pharma 40
Post-approval studies (Phase 4)Study completedNCT00629967
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Who this might be right for
Chronic Hepatitis CGenotype
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Not applicableStudy completedNCT07569211
What this trial is testing

Simplified HCV Integrated Management Model in Methadone Clinics in Ukraine

Who this might be right for
HCVOpioid Use Disorder
Ukrainian Institute on Public Health Policy 616
Testing effectiveness (Phase 2)Study completedNCT00959699
What this trial is testing

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Who this might be right for
HIV InfectionsHepatitis CHCV Infection
Merck Sharp & Dohme LLC 99
Post-approval studies (Phase 4)WithdrawnNCT03143998
What this trial is testing

Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT04513899
What this trial is testing

Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults

Who this might be right for
Hepatitis C Virus (HCV) Infection
University of California, Irvine 10
Testing effectiveness (Phase 2)WithdrawnNCT01579019
What this trial is testing

RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor Treatment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche
Post-approval studies (Phase 4)UnknownNCT03402165
What this trial is testing

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Sherief Abd-Elsalam 1,200
Large-scale testing (Phase 3)Study completedNCT02006745
What this trial is testing

Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

Who this might be right for
HIV
St Stephens Aids Trust 20
Testing effectiveness (Phase 2)Study completedNCT00035945
What this trial is testing

ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections

Who this might be right for
Hepatitis C, Chronic
Ionis Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT02105467
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

Who this might be right for
Chronic Hepatitis C Virus
Merck Sharp & Dohme LLC 421
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation